Arkolith/Insider Trading/BIAF/Form 4

Zannes Maria

President & CEObioAffinity Technologies, Inc. (BIAF) · full profile →Form 4 · filed Apr 24, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 8, 2024Tax withholding(F)28K$2.65$75K201K
Apr 8, 2024Option exercise(M)65K$1.16$75K230K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 8, 2024Option exercise(M)65K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-015791) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML